Dr. Susan Waisbren's research interests include long-term outcomes in metabolic and other genetic disorders. She has conducted studies in newborn screening outcomes and parental response to expanded newborn screening, investigating the impact of true and false positive identifications in terms of parental stress and utilization of healthcare resources. Current Research Neuroimaging in Metabolic Disorders: In collaboration with neurologists and experts in MRI Spectroscopy, Dr. Waisbren is investigating the underlying pathology in phenylketonuria (PKU), Galactosemia, and Urea Cycle Disorders. Through innovative imaging techniques in combination with neuropsychological evaluations, the research team aims to clarify the reasons for diverse outcomes in these metabolic disorders.